Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil may help with various hair loss types, but more research is needed.

The UK's EDS National Diagnostic Service found that early diagnosis, lifestyle advice, and regular check-ups are crucial for managing vascular Ehlers-Danlos syndrome. A combination of losartan and bisoprolol can reduce vascular events, improving survival and quality of life.

Isotretinoin can cause serious birth defects and needs careful use, especially in pregnant women.

Finasteride may lower depression risk in younger men with hair loss but increase it in older men with prostate issues.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Anabolic-androgenic steroids can harm women's health and their offspring.

PCOS is linked to obesity and inflammation, increasing cardiovascular risk.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Oral minoxidil 7.5 mg for hair loss increases heart rate but not blood pressure.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

New technologies help us understand how the body reacts to medical implants, which can improve implant performance.

Bioengineered microneedles and nanomedicine offer promising, precise treatments for tissue regeneration.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Early diagnosis and coordinated care are crucial for managing lupus effectively.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Integrating biological networks improves drug repurposing and ADR prediction.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

PCOS affects health and quality of life, with effective treatments available and a need for more research on alternative therapies.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.